Related Experiment Video
Updated: Aug 10, 2026

11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
[DTIC in the therapy of solid tumours (author's transl)]
Wiener Klinische Wochenschrift
|December 22, 1978
Summary
Dacarbazine (DTIC) showed limited efficacy in advanced solid tumors between 1975-1977. While monotherapy had low side effects, optimal dosing and combination therapies require further investigation for improved cancer treatment outcomes.
Area of Science:
- Medical Oncology
- Clinical Pharmacology
- Cancer Therapeutics
Context:
- Advanced solid tumors present significant treatment challenges.
- Chemotherapy remains a cornerstone of cancer treatment.
- Dacarbazine (DTIC) is an imidazole-carboxamide antineoplastic agent.
Purpose:
- To evaluate the efficacy and side effects of dacarbazine (DTIC) in patients with advanced solid tumors.
- To assess DTIC as both monotherapy and in combination with other cytostatic agents.
Summary:
- 42 patients with advanced solid tumors received DTIC between 1975-1977.
- Tumor remission was observed in melanoma, Kaposi sarcoma, and soft tissue sarcoma.
- DTIC monotherapy demonstrated comparably low side effects, but optimal dosage and frequency remain undetermined.
Impact:
- DTIC showed limited efficacy in this patient cohort.
- Further research is needed to establish optimal dosing and combination strategies for DTIC.
- The study highlights the ongoing need for effective treatments for advanced solid tumors.
Related Concept Videos
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

